Skip to main content

Daniel Bryce Landi

Associate Professor of Pediatrics
Pediatrics, Hematology-Oncology
Box 102382, Durham, NC 27710
330 Trent Drive, Room 390, Durham, NC 27710

Current Appointments & Affiliations


Associate Professor of Pediatrics · 2025 - Present Pediatrics, Hematology-Oncology, Pediatrics
Member of the Duke Cancer Institute · 2023 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published January 17, 2025
Randall Saladin’s Hopeful Journey at Duke Health

View All News

Recent Publications


A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4.

Journal Article Neuro Oncol · October 14, 2025 BACKGROUND: PBTC-029B was a phase 2 trial evaluating efficacy of selumetinib in children with recurrent/progressive low-grade glioma. We report results of strata 2, 5, and 6 with updated survivals for strata 1, 3, and 4. METHODS: Stratum 2 included recurre ... Full text Link to item Cite

A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial.

Journal Article Nat Cancer · September 2025 The human cytomegalovirus (CMV) antigen pp65 is expressed in high-grade glioma (HGG) and medulloblastoma but not in the adjacent brain. This single-arm phase 1 trial ( NCT03299309 ) assessed the safety and immunogenicity of a peptide vaccine (PEP-CMV) targ ... Full text Link to item Cite
View All Publications

Recent Grants


CONNECT1905: Phase 2 Study of Systemic IL-6 Receptor Antagonist ACTEMRA® (tocilizumab) for the treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma

Clinical TrialPrincipal Investigator · Awarded by Research Institute at Nationwide Children's Hospital · 2024 - 2029

PNOC037: A Phase 2 De-escalation Study of Dabrafenib and Trametinib for Patients with BRAF V600 Mutant Low-Grade Gliomas

Clinical TrialPrincipal Investigator · Awarded by The Regents of the University of California · 2025 - 2028

View All Grants

Education, Training & Certifications


University of Colorado, School of Medicine · 2009 M.D.